Biofrontera Inc.
BFRI | NASDAQ
$1.16
-$0.16 (-12.12%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
+$0.04 (+3.45%)
After-hours:
Sep 21, 2026, 7:57 PM ET
Market Data
Market Cap $16.9M
Enterprise Value $17.69M
Beta 0.84
Average Volume 377.3K
Shares Outstanding (Diluted) 12.31M
Shares Change YoY 38.2%
Institutional Ownership 20.47%
Exchange NASDAQ
ISIN US09077D2099
Price Performance
Price Change 1M -21.6%
Price Change 3M 12.6%
Price Change 6M 40.9%
Price Change YTD 60.0%
Price Change 1Y 14.8%
Price Change 3Y -87.4%
Price Change 5Y -98.7%
1M CAGR (ann.) 5.6%
1Y CAGR (ann.) 55.3%
5Y CAGR (ann.) N/A
All-Time CAGR -57.6%
Valuation
PE Ratio -2.00
Forward PE 7.25
PEG Ratio -0.01
Forward PEG 0.01
PS Ratio 0.32
Forward PS 0.30
PB Ratio 2.49
P/FCF Ratio -1.87
P/Adj. FCF Ratio -1.64
P/OCF Ratio -1.90
EV/Sales 0.38
EV/EBIT -3.13
EV/EBITDA -3.18
EV/FCF -2.23
Earnings Yield -50.0%
FCF Yield -53.4%
Adj. FCF Yield -61.0%
Financial Health
Net Cash $47K
Total Debt $7.5M
Cash & Short-Term Investments $4.67M
Total Assets $24.06M
Current Ratio 1.18
Quick Ratio 1.08
Debt / Equity Ratio 1.26
Debt / EBITDA -1.35
Debt / FCF -0.95
OCF / Debt -1.06
Interest Coverage -18.81
Altman Z-Score -5.96
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 84.5%
Operating Profit Margin -9.4%
EBITDA Margin -12.2%
Net Profit Margin -13.8%
FCF Margin -17.2%
Adj. FCF Margin -19.6%
SBC / Revenue 2.5%
SBC Impact (per share) -14.2%
Returns
Return on Assets -26.4%
Return on Equity -127.8%
Return on Invested Capital -31.2%
Return on Capital Employed -32.3%
Return on Tangible Assets -29.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 16.7%
Revenue CAGR 5Y 15.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 89.0%
EPS CAGR 5Y 77.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y 45.6%
FCF CAGR 5Y 29.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 1
EPS Growth Next 3Y 51.1%
Revenue Growth Next 3Y 23.2%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.22
EPS Growth Est (next Q) -62.7%
Revenue Est (next Q) $8.25M
Revenue Growth Est (next Q) 18.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3
Price Target Upside 158.6%
Cash Flow
Operating Cash Flow $-7.93M
Free Cash Flow $-7.93M
Adj. Free Cash Flow $-9.06M
FCF Per Share -$0.61
OCF Per Share -$0.61
OCF/S Ratio -17.2%
Income Statement
Revenue $46.18M
Gross Profit $39.22M
Operating Income $-4.36M
EBITDA $-5.56M
Net Income $-6.37M
EPS (Diluted) -$0.58
Revenue / Employee $518.82K
Profit / Employee $-71.52K
Employees 89
Add to Watchlist
Select watchlists to add or remove BFRI